A detailed history of New Age Alpha Advisors, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 9,218 shares of UTHR stock, worth $4.3 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
9,218
Previous 9,507 3.04%
Holding current value
$4.3 Million
Previous $2.73 Billion 41.45%
% of portfolio
0.16%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$274.7 - $438.75 $79,388 - $126,798
-289 Reduced 3.04%
9,218 $3.86 Billion
Q2 2025

Aug 11, 2025

BUY
$276.47 - $328.4 $95,382 - $113,297
345 Added 3.77%
9,507 $2.73 Billion
Q1 2025

May 09, 2025

BUY
$304.42 - $380.78 $1.38 Million - $1.72 Million
4,525 Added 97.58%
9,162 $2.82 Billion
Q4 2024

Feb 12, 2025

BUY
$348.66 - $410.0 $1.62 Million - $1.9 Million
4,637 New
4,637 $1.64 Billion

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $21.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track New Age Alpha Advisors, LLC Portfolio

Follow New Age Alpha Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Age Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Age Alpha Advisors, LLC with notifications on news.